Arrowhead Historical Income Statement
ARWR Stock | USD 25.24 0.62 2.52% |
Historical analysis of Arrowhead Pharmaceuticals income statement accounts such as Interest Expense of 20 M, Selling General Administrative of 79.1 M or Selling And Marketing Expenses of 8.2 B can show how well Arrowhead Pharmaceuticals performed in making a profits. Evaluating Arrowhead Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Arrowhead Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Arrowhead Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arrowhead Pharmaceuticals is a good buy for the upcoming year.
Arrowhead |
About Arrowhead Income Statement Analysis
Arrowhead Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Arrowhead Pharmaceuticals shareholders. The income statement also shows Arrowhead investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Arrowhead Pharmaceuticals Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Arrowhead Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Arrowhead Pharmaceuticals minus its cost of goods sold. It is profit before Arrowhead Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Arrowhead Pharmaceuticals. It is also known as Arrowhead Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Arrowhead Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Arrowhead Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.At this time, Arrowhead Pharmaceuticals' Income Tax Expense is relatively stable compared to the past year. As of 06/05/2024, Research Development is likely to grow to about 426.5 M, while Selling General Administrative is likely to drop slightly above 79.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.2M | 228.2M | 262.5M | 275.6M | Total Revenue | 243.2M | 240.7M | 276.8M | 290.7M |
Arrowhead Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Arrowhead Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arrowhead Pharmaceuticals income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 5.9M | 8.3M | 10.4M | 12.5M | 14.4M | 15.1M | |
Interest Expense | 9.2B | 6.1M | 5.0M | 18.3M | 21.1M | 20.0M | |
Selling General Administrative | 52.3M | 81.0M | 124.4M | 92.5M | 83.3M | 79.1M | |
Total Revenue | 88.0M | 138.3M | 243.2M | 240.7M | 276.8M | 290.7M | |
Gross Profit | 88.0M | 138.3M | 243.2M | 228.2M | 262.5M | 275.6M | |
Other Operating Expenses | 181.2M | 287.3M | 421.7M | 445.7M | 512.6M | 538.2M | |
Operating Income | (93.2M) | (149.0M) | (178.5M) | (205.0M) | (184.5M) | (175.3M) | |
Ebit | (93.2M) | (149.0M) | (178.5M) | (200.7M) | (180.6M) | (171.6M) | |
Ebitda | (87.2M) | (140.8M) | (168.1M) | (188.2M) | (169.3M) | (160.9M) | |
Total Operating Expenses | 181.2M | 287.3M | 421.7M | 445.7M | 512.6M | 538.2M | |
Income Before Tax | (84.6M) | (140.8M) | (172.7M) | (206.5M) | (185.8M) | (176.5M) | |
Total Other Income Expense Net | 8.6M | 8.2M | 5.8M | 1.5M | 1.8M | 888.4K | |
Net Income | (84.6M) | (140.8M) | (176.5M) | (205.3M) | (184.7M) | (175.5M) | |
Research Development | 128.9M | 206.3M | 297.3M | 353.2M | 406.2M | 426.5M | |
Net Income From Continuing Ops | (84.6M) | (140.8M) | (172.7M) | (209.3M) | (188.3M) | (178.9M) | |
Net Income Applicable To Common Shares | (84.6M) | (140.8M) | (176.1M) | (205.3M) | (184.7M) | (175.5M) | |
Net Interest Income | 9.2M | 6.1M | 5.0M | (3.0M) | (3.5M) | (3.3M) | |
Reconciled Depreciation | 5.9M | 8.3M | 10.4M | 12.5M | 14.4M | 8.0M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.